GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Debt-to-Revenue

MeCure Industries (NSA:MECURE) Debt-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

MeCure Industries's Short-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₦0.00 Mil. MeCure Industries's Long-Term Debt & Capital Lease Obligation for the quarter that ended in . 20 was ₦0.00 Mil. MeCure Industries's annualized Revenue for the quarter that ended in . 20 was ₦0.00 Mil.

MeCure Industries Debt-to-Revenue Historical Data

The historical data trend for MeCure Industries's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MeCure Industries Debt-to-Revenue Chart

MeCure Industries Annual Data
Trend
Debt-to-Revenue

MeCure Industries Semi-Annual Data
Debt-to-Revenue

Competitive Comparison of MeCure Industries's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, MeCure Industries's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MeCure Industries's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MeCure Industries's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where MeCure Industries's Debt-to-Revenue falls into.


MeCure Industries Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

MeCure Industries's Debt-to-Revenue for the fiscal year that ended in . 20 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=( + ) / N/A
=N/A

MeCure Industries's annualized Debt-to-Revenue for the quarter that ended in . 20 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=( + ) / 0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is one times the quarterly (. 20) Revenue data.

MeCure Industries Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of MeCure Industries's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

MeCure Industries Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » Debt-to-Revenue
Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
Website
https://www.mecure.com
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines